Two new studies take significant steps toward interventions to reduce cardiac risk in humans by reducing levels of the metabolite TMAO through diet manipulation or targeted therapies.
Nonlethal Targeting of Gut Microbes Successfully Treats Atherosclerosis
The story linking gut microbes, TMAO and heart disease has turned toward therapy interventions with the first demonstrated targeting of a gut microbial pathway to curb diet-induced heart disease.